87 related articles for article (PubMed ID: 3104595)
1. The effect of corticosteroids and other antineoplastic agents on the generation of leukocyte migration inhibition factor.
Li J; Yousefi S; Sterling M; Carandang G; Vaziri N; Pahl M; Cesario T
J Clin Lab Immunol; 1987 Jan; 22(1):13-7. PubMed ID: 3104595
[TBL] [Abstract][Full Text] [Related]
2. Monocyte regulation of lymphokine production in cancer patients.
Kowalczyk D; Ruggiero I; Zembala M
J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
[TBL] [Abstract][Full Text] [Related]
3. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients].
Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796
[TBL] [Abstract][Full Text] [Related]
4. Effects of indomethacin on lymphocyte proliferation, suppressor cell function, and leukocyte migration inhibitory factor (lmif) production.
Soppi E; Eskola J; Ruuskanen O
Immunopharmacology; 1982 Jun; 4(3):235-42. PubMed ID: 6213582
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
Wahl SM; Altman LC; Rosenstreich DL
J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine-supressing cells in patients after kidney transplantation.
Górski A; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):965-8. PubMed ID: 373693
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
Crivii SM; Crişan M; Crişan M
Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
[TBL] [Abstract][Full Text] [Related]
8. Differential in vitro effects of etretinate and retinoic acid on the PHA and con A induced lymphocyte transformation, suppressor cell induction and leukocyte migration inhibitory factor (LMIF) production.
Soppi E; Tertti R; Soppi AM; Toivanen A; Jansén CT
Int J Immunopharmacol; 1982; 4(5):437-43. PubMed ID: 6215368
[TBL] [Abstract][Full Text] [Related]
9. The effect of hydrocortisone on the production of gamma-interferon and other lymphokines by human peripheral blood mononuclear cells.
Cesario TC; Slater L; Poo WJ; Spindler B; Walter B; Gorse G; Carandang G
J Interferon Res; 1986 Aug; 6(4):337-47. PubMed ID: 3021873
[TBL] [Abstract][Full Text] [Related]
10. Cellular collaboration in the production of human leucocyte migration inhibition factor.
Weisbart RH; Yu DT; Billing R; Fan PT; Clements PJ; Paulus HE
Immunology; 1978 May; 34(5):815-9. PubMed ID: 306961
[TBL] [Abstract][Full Text] [Related]
11. Direct stimulation of lymphokine production by cephalothin.
Larson SE; DaMert GJ; Collins-Lech C; Sohnle PG
J Infect Dis; 1980 Aug; 142(2):265-72. PubMed ID: 6997406
[TBL] [Abstract][Full Text] [Related]
12. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas.
Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G
Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629
[TBL] [Abstract][Full Text] [Related]
13. Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes.
Arvilommi H; Räsänen L
Immunology; 1980 Aug; 40(4):695-700. PubMed ID: 6448804
[TBL] [Abstract][Full Text] [Related]
14. Differential role of Zn2+ in antigen- and mitogen-induced lymphokine production.
Bendtzen K
Scand J Immunol; 1980; 12(6):489-92. PubMed ID: 7017904
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma].
Uno K
Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
Górski AJ; Dupont B; Hansen JA; O'Reilly R; Smithwick E; Górska R; Good RA
Clin Exp Immunol; 1976 Dec; 26(3):505-10. PubMed ID: 795576
[TBL] [Abstract][Full Text] [Related]
17. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
Center DM; Cruikshank WW; Berman JS; Beer DJ
J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporin A (CyA) and methylprednisolone (MP) on the immune response. II. Further studies of the monocyte - T cell interactions leading to lymphokine production.
Bendtzen K; Petersen J; Søeberg B
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):159-67. PubMed ID: 6308952
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein synthesis and lymphokine production by tetracycline.
Ganguly R; Pennock DG; Kluge RM
Allerg Immunol (Leipz); 1984; 30(2):104-9. PubMed ID: 6237556
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
